Global Radiopharmaceuticals in Nuclear Medicine Market Insights and Forecast to 2028

  • Report ID:198113
  • Industry Name: Pharma & Healthcare
  • Publishing Date: Apr-22
  • No. of Pages: 125
                              
Radiopharmaceuticals in Nuclear Medicine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Radiopharmaceuticals in Nuclear Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Diagnostic Radiopharmaceuticals Therapy Radiopharmaceuticals Enriched Stable Isotopes Segment by Application Diagnostic Application Therapeutic Application Research Pharmaceutical Other By Company Bracco Imaging S.P.A. Cambridge Isotope Laboratories, Inc. Cardinal Health, Inc. Covidien, Plc Eczacibasi-Monrol Fujifilm Holdings Corporation GE Healthcare (Subsidiary Of General Electric Company) IBA Group Isotec, Inc. (Sigma-Aldrich) Lantheus Medical Imaging, Inc. Nordion, Inc. Ntp Radioisotopes (Pty), Ltd. Siemens Healthcare (Subsidiary Of Siemens AG) Taiyo Nippon Sanso Corporation Urenco Limited Rotem Industries, Ltd., Inc. Australian Nuclear Association And Technology Organization (ANSTO) Board of Radiation And Isotope Technology (BRIT) Institute of Atomic Energy Polatom Radioisotope Centre Institute of Isotopes Co., Ltd. Institute Of Radioelement (IRE) By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E
                        
1 Study Coverage 1.1 Radiopharmaceuticals in Nuclear Medicine Product Introduction 1.2 Market by Type 1.2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Diagnostic Radiopharmaceuticals 1.2.3 Therapy Radiopharmaceuticals 1.2.4 Enriched Stable Isotopes 1.3 Market by Application 1.3.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Diagnostic Application 1.3.3 Therapeutic Application 1.3.4 Research 1.3.5 Pharmaceutical 1.3.6 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Estimates and Forecasts 2017-2028 2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Estimates and Forecasts 2017-2028 2.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Radiopharmaceuticals in Nuclear Medicine Sales by Region 2.4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2017-2022) 2.4.2 Global Sales Radiopharmaceuticals in Nuclear Medicine by Region (2023-2028) 2.5 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region 2.5.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2022) 2.5.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers 3.1.1 Global Top Radiopharmaceuticals in Nuclear Medicine Manufacturers by Sales (2017-2022) 3.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Radiopharmaceuticals in Nuclear Medicine in 2021 3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers 3.2.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2017-2022) 3.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Radiopharmaceuticals in Nuclear Medicine Revenue in 2021 3.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Radiopharmaceuticals in Nuclear Medicine Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Type 4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Historical Sales by Type (2017-2022) 4.1.2 Global Radiopharmaceuticals in Nuclear Medicine Forecasted Sales by Type (2023-2028) 4.1.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028) 4.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type 4.2.1 Global Radiopharmaceuticals in Nuclear Medicine Historical Revenue by Type (2017-2022) 4.2.2 Global Radiopharmaceuticals in Nuclear Medicine Forecasted Revenue by Type (2023-2028) 4.2.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2028) 4.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Type 4.3.1 Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2017-2022) 4.3.2 Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Application 5.1.1 Global Radiopharmaceuticals in Nuclear Medicine Historical Sales by Application (2017-2022) 5.1.2 Global Radiopharmaceuticals in Nuclear Medicine Forecasted Sales by Application (2023-2028) 5.1.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028) 5.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application 5.2.1 Global Radiopharmaceuticals in Nuclear Medicine Historical Revenue by Application (2017-2022) 5.2.2 Global Radiopharmaceuticals in Nuclear Medicine Forecasted Revenue by Application (2023-2028) 5.2.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2017-2028) 5.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Application 5.3.1 Global Radiopharmaceuticals in Nuclear Medicine Price by Application (2017-2022) 5.3.2 Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Application (2023-2028) 6 North America 6.1 North America Radiopharmaceuticals in Nuclear Medicine Market Size by Type 6.1.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028) 6.1.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2028) 6.2 North America Radiopharmaceuticals in Nuclear Medicine Market Size by Application 6.2.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028) 6.2.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2028) 6.3 North America Radiopharmaceuticals in Nuclear Medicine Market Size by Country 6.3.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2028) 6.3.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Type 7.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028) 7.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2028) 7.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Application 7.2.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028) 7.2.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2028) 7.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country 7.3.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2028) 7.3.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Type 8.1.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028) 8.1.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2028) 8.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Application 8.2.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028) 8.2.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2028) 8.3 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Region 8.3.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region (2017-2028) 8.3.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Radiopharmaceuticals in Nuclear Medicine Market Size by Type 9.1.1 Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028) 9.1.2 Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2028) 9.2 Latin America Radiopharmaceuticals in Nuclear Medicine Market Size by Application 9.2.1 Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028) 9.2.2 Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2028) 9.3 Latin America Radiopharmaceuticals in Nuclear Medicine Market Size by Country 9.3.1 Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2028) 9.3.2 Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Type 10.1.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028) 10.1.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2028) 10.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Application 10.2.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028) 10.2.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2028) 10.3 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Country 10.3.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2028) 10.3.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Bracco Imaging S.P.A. 11.1.1 Bracco Imaging S.P.A. Corporation Information 11.1.2 Bracco Imaging S.P.A. Overview 11.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Bracco Imaging S.P.A. Recent Developments 11.2 Cambridge Isotope Laboratories, Inc. 11.2.1 Cambridge Isotope Laboratories, Inc. Corporation Information 11.2.2 Cambridge Isotope Laboratories, Inc. Overview 11.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Cambridge Isotope Laboratories, Inc. Recent Developments 11.3 Cardinal Health, Inc. 11.3.1 Cardinal Health, Inc. Corporation Information 11.3.2 Cardinal Health, Inc. Overview 11.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Cardinal Health, Inc. Recent Developments 11.4 Covidien, Plc 11.4.1 Covidien, Plc Corporation Information 11.4.2 Covidien, Plc Overview 11.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Covidien, Plc Recent Developments 11.5 Eczacibasi-Monrol 11.5.1 Eczacibasi-Monrol Corporation Information 11.5.2 Eczacibasi-Monrol Overview 11.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Eczacibasi-Monrol Recent Developments 11.6 Fujifilm Holdings Corporation 11.6.1 Fujifilm Holdings Corporation Corporation Information 11.6.2 Fujifilm Holdings Corporation Overview 11.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Fujifilm Holdings Corporation Recent Developments 11.7 GE Healthcare (Subsidiary Of General Electric Company) 11.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information 11.7.2 GE Healthcare (Subsidiary Of General Electric Company) Overview 11.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Developments 11.8 IBA Group 11.8.1 IBA Group Corporation Information 11.8.2 IBA Group Overview 11.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 IBA Group Recent Developments 11.9 Isotec, Inc. (Sigma-Aldrich) 11.9.1 Isotec, Inc. (Sigma-Aldrich) Corporation Information 11.9.2 Isotec, Inc. (Sigma-Aldrich) Overview 11.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Isotec, Inc. (Sigma-Aldrich) Recent Developments 11.10 Lantheus Medical Imaging, Inc. 11.10.1 Lantheus Medical Imaging, Inc. Corporation Information 11.10.2 Lantheus Medical Imaging, Inc. Overview 11.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Lantheus Medical Imaging, Inc. Recent Developments 11.11 Nordion, Inc. 11.11.1 Nordion, Inc. Corporation Information 11.11.2 Nordion, Inc. Overview 11.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Nordion, Inc. Recent Developments 11.12 Ntp Radioisotopes (Pty), Ltd. 11.12.1 Ntp Radioisotopes (Pty), Ltd. Corporation Information 11.12.2 Ntp Radioisotopes (Pty), Ltd. Overview 11.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 Ntp Radioisotopes (Pty), Ltd. Recent Developments 11.13 Siemens Healthcare (Subsidiary Of Siemens AG) 11.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Corporation Information 11.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Overview 11.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 Siemens Healthcare (Subsidiary Of Siemens AG) Recent Developments 11.14 Taiyo Nippon Sanso Corporation 11.14.1 Taiyo Nippon Sanso Corporation Corporation Information 11.14.2 Taiyo Nippon Sanso Corporation Overview 11.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.14.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.14.5 Taiyo Nippon Sanso Corporation Recent Developments 11.15 Urenco Limited 11.15.1 Urenco Limited Corporation Information 11.15.2 Urenco Limited Overview 11.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.15.4 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.15.5 Urenco Limited Recent Developments 11.16 Rotem Industries, Ltd., Inc. 11.16.1 Rotem Industries, Ltd., Inc. Corporation Information 11.16.2 Rotem Industries, Ltd., Inc. Overview 11.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.16.4 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.16.5 Rotem Industries, Ltd., Inc. Recent Developments 11.17 Australian Nuclear Association And Technology Organization (ANSTO) 11.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Corporation Information 11.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Overview 11.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.17.5 Australian Nuclear Association And Technology Organization (ANSTO) Recent Developments 11.18 Board of Radiation And Isotope Technology (BRIT) 11.18.1 Board of Radiation And Isotope Technology (BRIT) Corporation Information 11.18.2 Board of Radiation And Isotope Technology (BRIT) Overview 11.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.18.4 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.18.5 Board of Radiation And Isotope Technology (BRIT) Recent Developments 11.19 Institute of Atomic Energy Polatom Radioisotope Centre 11.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Corporation Information 11.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Overview 11.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.19.5 Institute of Atomic Energy Polatom Radioisotope Centre Recent Developments 11.20 Institute of Isotopes Co., Ltd. 11.20.1 Institute of Isotopes Co., Ltd. Corporation Information 11.20.2 Institute of Isotopes Co., Ltd. Overview 11.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.20.4 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.20.5 Institute of Isotopes Co., Ltd. Recent Developments 11.21 Institute Of Radioelement (IRE) 11.21.1 Institute Of Radioelement (IRE) Corporation Information 11.21.2 Institute Of Radioelement (IRE) Overview 11.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2017-2022) 11.21.4 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications 11.21.5 Institute Of Radioelement (IRE) Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Radiopharmaceuticals in Nuclear Medicine Industry Chain Analysis 12.2 Radiopharmaceuticals in Nuclear Medicine Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Radiopharmaceuticals in Nuclear Medicine Production Mode & Process 12.4 Radiopharmaceuticals in Nuclear Medicine Sales and Marketing 12.4.1 Radiopharmaceuticals in Nuclear Medicine Sales Channels 12.4.2 Radiopharmaceuticals in Nuclear Medicine Distributors 12.5 Radiopharmaceuticals in Nuclear Medicine Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Radiopharmaceuticals in Nuclear Medicine Industry Trends 13.2 Radiopharmaceuticals in Nuclear Medicine Market Drivers 13.3 Radiopharmaceuticals in Nuclear Medicine Market Challenges 13.4 Radiopharmaceuticals in Nuclear Medicine Market Restraints 14 Key Findings in The Global Radiopharmaceuticals in Nuclear Medicine Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
                
List of Tables Table 1. Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Diagnostic Radiopharmaceuticals Table 3. Major Manufacturers of Therapy Radiopharmaceuticals Table 4. Major Manufacturers of Enriched Stable Isotopes Table 5. Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 7. Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2017-2022) & (K MT) Table 8. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2017-2022) Table 9. Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2023-2028) & (K MT) Table 10. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2023-2028) Table 11. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2022) & (US$ Million) Table 12. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2017-2022) Table 13. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2023-2028) & (US$ Million) Table 14. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2023-2028) Table 15. Global Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers (2017-2022) & (K MT) Table 16. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Manufacturers (2017-2022) Table 17. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2017-2022) & (US$ Million) Table 18. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2017-2022) Table 19. Radiopharmaceuticals in Nuclear Medicine Price by Manufacturers (2017-2022) &(USD/MT) Table 20. Global Radiopharmaceuticals in Nuclear Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 21. Global Radiopharmaceuticals in Nuclear Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals in Nuclear Medicine as of 2021) Table 22. Radiopharmaceuticals in Nuclear Medicine Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Offered Table 24. Date of Manufacturers Enter into Radiopharmaceuticals in Nuclear Medicine Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT) Table 27. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT) Table 28. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2017-2022) Table 29. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2023-2028) Table 30. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2022) & (US$ Million) Table 31. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2023-2028) & (US$ Million) Table 32. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2017-2022) Table 33. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2023-2028) Table 34. Radiopharmaceuticals in Nuclear Medicine Price by Type (2017-2022) & (USD/MT) Table 35. Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Type (2023-2028) & (USD/MT) Table 36. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT) Table 37. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT) Table 38. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Application (2017-2022) Table 39. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Application (2023-2028) Table 40. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2022) & (US$ Million) Table 41. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2023-2028) & (US$ Million) Table 42. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Application (2017-2022) Table 43. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Application (2023-2028) Table 44. Radiopharmaceuticals in Nuclear Medicine Price by Application (2017-2022) & (USD/MT) Table 45. Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Application (2023-2028) & (USD/MT) Table 46. North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT) Table 47. North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT) Table 48. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2022) & (US$ Million) Table 49. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2023-2028) & (US$ Million) Table 50. North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT) Table 51. North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT) Table 52. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2022) & (US$ Million) Table 53. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2023-2028) & (US$ Million) Table 54. North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022) & (K MT) Table 55. North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2023-2028) & (K MT) Table 56. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022) & (US$ Million) Table 57. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2023-2028) & (US$ Million) Table 58. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT) Table 59. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT) Table 60. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2022) & (US$ Million) Table 61. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2023-2028) & (US$ Million) Table 62. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT) Table 63. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT) Table 64. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2022) & (US$ Million) Table 65. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2023-2028) & (US$ Million) Table 66. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022) & (K MT) Table 67. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2023-2028) & (K MT) Table 68. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022) & (US$ Million) Table 69. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2023-2028) & (US$ Million) Table 70. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT) Table 71. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT) Table 72. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2022) & (US$ Million) Table 73. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2023-2028) & (US$ Million) Table 74. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT) Table 75. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT) Table 76. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2022) & (US$ Million) Table 77. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2023-2028) & (US$ Million) Table 78. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region (2017-2022) & (K MT) Table 79. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region (2023-2028) & (K MT) Table 80. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2022) & (US$ Million) Table 81. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2023-2028) & (US$ Million) Table 82. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT) Table 83. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT) Table 84. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2022) & (US$ Million) Table 85. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2023-2028) & (US$ Million) Table 86. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT) Table 87. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT) Table 88. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2022) & (US$ Million) Table 89. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2023-2028) & (US$ Million) Table 90. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022) & (K MT) Table 91. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2023-2028) & (K MT) Table 92. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022) & (US$ Million) Table 93. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2023-2028) & (US$ Million) Table 94. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2022) & (K MT) Table 95. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2023-2028) & (K MT) Table 96. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2022) & (US$ Million) Table 97. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2023-2028) & (US$ Million) Table 98. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2022) & (K MT) Table 99. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application (2023-2028) & (K MT) Table 100. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2022) & (US$ Million) Table 101. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2023-2028) & (US$ Million) Table 102. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country (2017-2022) & (K MT) Table 103. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country (2023-2028) & (K MT) Table 104. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2022) & (US$ Million) Table 105. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2023-2028) & (US$ Million) Table 106. Bracco Imaging S.P.A. Corporation Information Table 107. Bracco Imaging S.P.A. Description and Major Businesses Table 108. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 109. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 110. Bracco Imaging S.P.A. Recent Developments Table 111. Cambridge Isotope Laboratories, Inc. Corporation Information Table 112. Cambridge Isotope Laboratories, Inc. Description and Major Businesses Table 113. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 114. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 115. Cambridge Isotope Laboratories, Inc. Recent Developments Table 116. Cardinal Health, Inc. Corporation Information Table 117. Cardinal Health, Inc. Description and Major Businesses Table 118. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 119. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 120. Cardinal Health, Inc. Recent Developments Table 121. Covidien, Plc Corporation Information Table 122. Covidien, Plc Description and Major Businesses Table 123. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 124. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 125. Covidien, Plc Recent Developments Table 126. Eczacibasi-Monrol Corporation Information Table 127. Eczacibasi-Monrol Description and Major Businesses Table 128. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 129. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 130. Eczacibasi-Monrol Recent Developments Table 131. Fujifilm Holdings Corporation Corporation Information Table 132. Fujifilm Holdings Corporation Description and Major Businesses Table 133. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 134. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 135. Fujifilm Holdings Corporation Recent Developments Table 136. GE Healthcare (Subsidiary Of General Electric Company) Corporation Information Table 137. GE Healthcare (Subsidiary Of General Electric Company) Description and Major Businesses Table 138. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 139. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 140. GE Healthcare (Subsidiary Of General Electric Company) Recent Developments Table 141. IBA Group Corporation Information Table 142. IBA Group Description and Major Businesses Table 143. IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 144. IBA Group Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 145. IBA Group Recent Developments Table 146. Isotec, Inc. (Sigma-Aldrich) Corporation Information Table 147. Isotec, Inc. (Sigma-Aldrich) Description and Major Businesses Table 148. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 149. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 150. Isotec, Inc. (Sigma-Aldrich) Recent Developments Table 151. Lantheus Medical Imaging, Inc. Corporation Information Table 152. Lantheus Medical Imaging, Inc. Description and Major Businesses Table 153. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 154. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 155. Lantheus Medical Imaging, Inc. Recent Developments Table 156. Nordion, Inc. Corporation Information Table 157. Nordion, Inc. Description and Major Businesses Table 158. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 159. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 160. Nordion, Inc. Recent Developments Table 161. Ntp Radioisotopes (Pty), Ltd. Corporation Information Table 162. Ntp Radioisotopes (Pty), Ltd. Description and Major Businesses Table 163. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 164. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 165. Ntp Radioisotopes (Pty), Ltd. Recent Developments Table 166. Siemens Healthcare (Subsidiary Of Siemens AG) Corporation Information Table 167. Siemens Healthcare (Subsidiary Of Siemens AG) Description and Major Businesses Table 168. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 169. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 170. Siemens Healthcare (Subsidiary Of Siemens AG) Recent Developments Table 171. Taiyo Nippon Sanso Corporation Corporation Information Table 172. Taiyo Nippon Sanso Corporation Description and Major Businesses Table 173. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 174. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 175. Taiyo Nippon Sanso Corporation Recent Developments Table 176. Urenco Limited Corporation Information Table 177. Urenco Limited Description and Major Businesses Table 178. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 179. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 180. Urenco Limited Recent Developments Table 181. Rotem Industries, Ltd., Inc. Corporation Information Table 182. Rotem Industries, Ltd., Inc. Description and Major Businesses Table 183. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 184. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 185. Rotem Industries, Ltd., Inc. Recent Developments Table 186. Australian Nuclear Association And Technology Organization (ANSTO) Corporation Information Table 187. Australian Nuclear Association And Technology Organization (ANSTO) Description and Major Businesses Table 188. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 189. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 190. Australian Nuclear Association And Technology Organization (ANSTO) Recent Developments Table 191. Board of Radiation And Isotope Technology (BRIT) Corporation Information Table 192. Board of Radiation And Isotope Technology (BRIT) Description and Major Businesses Table 193. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 194. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 195. Board of Radiation And Isotope Technology (BRIT) Recent Developments Table 196. Institute of Atomic Energy Polatom Radioisotope Centre Corporation Information Table 197. Institute of Atomic Energy Polatom Radioisotope Centre Description and Major Businesses Table 198. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 199. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 200. Institute of Atomic Energy Polatom Radioisotope Centre Recent Developments Table 201. Institute of Isotopes Co., Ltd. Corporation Information Table 202. Institute of Isotopes Co., Ltd. Description and Major Businesses Table 203. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 204. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 205. Institute of Isotopes Co., Ltd. Recent Developments Table 206. Institute Of Radioelement (IRE) Corporation Information Table 207. Institute Of Radioelement (IRE) Description and Major Businesses Table 208. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 209. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications Table 210. Institute Of Radioelement (IRE) Recent Developments Table 211. Key Raw Materials Lists Table 212. Raw Materials Key Suppliers Lists Table 213. Radiopharmaceuticals in Nuclear Medicine Distributors List Table 214. Radiopharmaceuticals in Nuclear Medicine Customers List Table 215. Radiopharmaceuticals in Nuclear Medicine Market Trends Table 216. Radiopharmaceuticals in Nuclear Medicine Market Drivers Table 217. Radiopharmaceuticals in Nuclear Medicine Market Challenges Table 218. Radiopharmaceuticals in Nuclear Medicine Market Restraints Table 219. Research Programs/Design for This Report Table 220. Key Data Information from Secondary Sources Table 221. Key Data Information from Primary Sources List of Figures Figure 1. Radiopharmaceuticals in Nuclear Medicine Product Picture Figure 3. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2021 & 2028 Figure 3. Diagnostic Radiopharmaceuticals Product Picture Figure 4. Therapy Radiopharmaceuticals Product Picture Figure 5. Enriched Stable Isotopes Product Picture Figure 6. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2021 & 2028 Figure 7. Diagnostic Application Figure 8. Therapeutic Application Figure 9. Research Figure 10. Pharmaceutical Figure 11. Other Figure 12. Radiopharmaceuticals in Nuclear Medicine Report Years Considered Figure 13. Global Radiopharmaceuticals in Nuclear Medicine Sales 2017-2028 (K MT) Figure 14. Global Radiopharmaceuticals in Nuclear Medicine Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Radiopharmaceuticals in Nuclear Medicine Revenue 2017-2028 (US$ Million) Figure 16. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 17. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2017-2022) Figure 18. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2023-2028) Figure 19. North America Radiopharmaceuticals in Nuclear Medicine Sales YoY (2017-2028) & (K MT) Figure 20. North America Radiopharmaceuticals in Nuclear Medicine Revenue YoY (2017-2028) & (US$ Million) Figure 21. Europe Radiopharmaceuticals in Nuclear Medicine Sales YoY (2017-2028) & (K MT) Figure 22. Europe Radiopharmaceuticals in Nuclear Medicine Revenue YoY (2017-2028) & (US$ Million) Figure 23. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales YoY (2017-2028) & (K MT) Figure 24. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue YoY (2017-2028) & (US$ Million) Figure 25. Latin America Radiopharmaceuticals in Nuclear Medicine Sales YoY (2017-2028) & (K MT) Figure 26. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue YoY (2017-2028) & (US$ Million) Figure 27. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales YoY (2017-2028) & (K MT) Figure 28. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue YoY (2017-2028) & (US$ Million) Figure 29. The Radiopharmaceuticals in Nuclear Medicine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 30. The Top 5 and 10 Largest Manufacturers of Radiopharmaceuticals in Nuclear Medicine in the World: Market Share by Radiopharmaceuticals in Nuclear Medicine Revenue in 2021 Figure 31. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 32. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028) Figure 33. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2028) Figure 34. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028) Figure 35. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2017-2028) Figure 36. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028) Figure 37. North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2028) Figure 38. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028) Figure 39. North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2017-2028) Figure 40. North America Radiopharmaceuticals in Nuclear Medicine Sales Share by Country (2017-2028) Figure 41. North America Radiopharmaceuticals in Nuclear Medicine Revenue Share by Country (2017-2028) Figure 42. U.S. Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 43. Canada Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 44. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028) Figure 45. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2028) Figure 46. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028) Figure 47. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2017-2028) Figure 48. Europe Radiopharmaceuticals in Nuclear Medicine Sales Share by Country (2017-2028) Figure 49. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Share by Country (2017-2028) Figure 50. Germany Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 51. France Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 52. U.K. Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 53. Italy Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 54. Russia Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 55. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028) Figure 56. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2028) Figure 57. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028) Figure 58. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2017-2028) Figure 59. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Share by Region (2017-2028) Figure 60. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Share by Region (2017-2028) Figure 61. China Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 62. Japan Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 63. South Korea Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 64. India Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 65. Australia Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 66. Taiwan Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 67. Indonesia Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 68. Thailand Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 69. Malaysia Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 70. Philippines Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028) & (US$ Million) Figure 71. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2017-2028) Figure 72. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2017-2028) Figure 73. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2017-2028) Figure 74. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.